Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kewei Chen

Showing results (471-480 of 511) with videos related to

Pageof 52
Sort By:
JAMA Neurology|July 23, 2019
Effect of AZD0530 on Cerebral Metabolic Decline in Alzheimer Disease: A Randomized Clinical TrialChristopher H van Dyck, Haakon B Nygaard, Kewei Chen, et al.
Scientific Reports|April 14, 2025
Divergent neurodegeneration associations with choroid plexus volume and degree of calcification in cognitively normal APOE ε4 carriers and non-carriersIlker Ozsahin, Xiuyuan Wang, Liangdong Zhou, et al.
Neurobiology of Aging|May 29, 2012
Apolipoprotein E ε4 and age effects on florbetapir positron emission tomography in healthy aging and Alzheimer diseaseAdam S Fleisher, Kewei Chen, Xiaofen Liu, et al.
Alzheimer'S & Dementia (New York, N. Y.)|June 30, 2018
The Alzheimer's Prevention Initiative Autosomal-Dominant Alzheimer's Disease Trial: A study of crenezumab versus placebo in preclinical <i>PSEN1</i> E280A mutation carriers to evaluate efficacy and safety in the treatment of autosomal-dominant Alzheimer's disease, including a placebo-treated noncarrier cohortPierre N Tariot, Francisco Lopera, Jessica B Langbaum, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 1, 2021
Early prevention of cognitive impairment in the community population: The Beijing Aging Brain Rejuvenation InitiativeCaishui Yang, Xin Li, Junying Zhang, et al.
Neuroimage|February 1, 2011
Characterizing Alzheimer's disease using a hypometabolic convergence indexKewei Chen, Napatkamon Ayutyanont, Jessica B S Langbaum, et al.
Journal of Neuropathology and Experimental Neurology|June 1, 2026
Multisite study: Predicting Lewy body disease using skin biopsy α-synuclein seed amplification assaysChelva Janarthanam, Christina D Orrú, Andrew G Hughson, et al.
Advanced Materials (Deerfield Beach, Fla.)|March 8, 2022
Upcycling Silicon Photovoltaic Waste into ThermoelectricsJing Cao, Ying Sim, Xian Yi Tan, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 26, 2022
Plasma p-tau217 predicts in vivo brain pathology and cognition in autosomal dominant Alzheimer's diseaseDavid Aguillon, Stephanie Langella, Yinghua Chen, et al.
JAMA Neurology|January 13, 2015
Associations between biomarkers and age in the presenilin 1 E280A autosomal dominant Alzheimer disease kindred: a cross-sectional studyAdam S Fleisher, Kewei Chen, Yakeel T Quiroz, et al.
Pageof 52

Showing results (471-480 of 511) with videos related to

Sort By:
Pageof 52
JAMA Neurology|July 23, 2019
Effect of AZD0530 on Cerebral Metabolic Decline in Alzheimer Disease: A Randomized Clinical TrialChristopher H van Dyck, Haakon B Nygaard, Kewei Chen, et al.
Scientific Reports|April 14, 2025
Divergent neurodegeneration associations with choroid plexus volume and degree of calcification in cognitively normal APOE ε4 carriers and non-carriersIlker Ozsahin, Xiuyuan Wang, Liangdong Zhou, et al.
Neurobiology of Aging|May 29, 2012
Apolipoprotein E ε4 and age effects on florbetapir positron emission tomography in healthy aging and Alzheimer diseaseAdam S Fleisher, Kewei Chen, Xiaofen Liu, et al.
Alzheimer'S & Dementia (New York, N. Y.)|June 30, 2018
The Alzheimer's Prevention Initiative Autosomal-Dominant Alzheimer's Disease Trial: A study of crenezumab versus placebo in preclinical <i>PSEN1</i> E280A mutation carriers to evaluate efficacy and safety in the treatment of autosomal-dominant Alzheimer's disease, including a placebo-treated noncarrier cohortPierre N Tariot, Francisco Lopera, Jessica B Langbaum, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 1, 2021
Early prevention of cognitive impairment in the community population: The Beijing Aging Brain Rejuvenation InitiativeCaishui Yang, Xin Li, Junying Zhang, et al.
Neuroimage|February 1, 2011
Characterizing Alzheimer's disease using a hypometabolic convergence indexKewei Chen, Napatkamon Ayutyanont, Jessica B S Langbaum, et al.
Journal of Neuropathology and Experimental Neurology|June 1, 2026
Multisite study: Predicting Lewy body disease using skin biopsy α-synuclein seed amplification assaysChelva Janarthanam, Christina D Orrú, Andrew G Hughson, et al.
Advanced Materials (Deerfield Beach, Fla.)|March 8, 2022
Upcycling Silicon Photovoltaic Waste into ThermoelectricsJing Cao, Ying Sim, Xian Yi Tan, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 26, 2022
Plasma p-tau217 predicts in vivo brain pathology and cognition in autosomal dominant Alzheimer's diseaseDavid Aguillon, Stephanie Langella, Yinghua Chen, et al.
JAMA Neurology|January 13, 2015
Associations between biomarkers and age in the presenilin 1 E280A autosomal dominant Alzheimer disease kindred: a cross-sectional studyAdam S Fleisher, Kewei Chen, Yakeel T Quiroz, et al.
Pageof 52